Cargando…

Estimating the burden of adult hospitalized RSV infection using local and state data - methodology

Respiratory syncytial virus (RSV) is becoming increasingly recognized as a serious threat to vulnerable population subgroups. This study describes the statistical analysis plan for a retrospective cohort study of adults hospitalized for acute respiratory infection (ARI) to estimate the population bu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balasubramani, G. K., Nowalk, Mary Patricia, Eng, Heather, Zimmerman, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Novel Vaccines – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920185/ https://www.ncbi.nlm.nih.gov/pubmed/35271432 http://dx.doi.org/10.1080/21645515.2021.1958610

Ejemplares similares

Correlative outcomes of maternal immunization against RSV in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2022)

Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
por: Galgani, Ilaria, et al.
Publicado: (2023)

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
por: Wang, Yiping, et al.
Publicado: (2023)

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
por: Chaudhary, Shipra, et al.
Publicado: (2023)

The applications of animal models in phage therapy: An update
por: Mehmood Khan, Fazal, et al.
Publicado: (2023)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
por: Huang, Xiaoyuan, et al.
Publicado: (2023)

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
por: López, Pio, et al.
Publicado: (2023)

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023)

Analysis and prediction of the incidence and prevalence trends of gonorrhea in China
por: Chen, Xueya, et al.
Publicado: (2023)

An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life
por: Patel, Sanjay S., et al.
Publicado: (2023)

Advancements in the development of nucleic acid vaccines for syphilis prevention and control
por: Li, Sijia, et al.
Publicado: (2023)

Acceptability for the influenza virus vector COVID-19 vaccine for intranasal spray: A cross-sectional survey in Beijing, China
por: Ma, Yuan, et al.
Publicado: (2023)

Challenges in development of vaccines directed toward antimicrobial resistant bacterial species
por: Brazzoli, Michela, et al.
Publicado: (2023)

Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination
por: Levine, Min Z., et al.
Publicado: (2016)

Comparison of local influenza vaccine effectiveness using two methods
por: Balasubramani, G.K., et al.
Publicado: (2021)

Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017
por: Heppe Montero, Marco, et al.
Publicado: (2021)

Disease burden in patients with severe hand, foot, and mouth disease in Jiangsu Province: a cross-sectional study
por: Han, Ying, et al.
Publicado: (2022)

Immune camouflage: Relevance to vaccines and human immunology
por: De Groot, Anne S, et al.
Publicado: (2014)

Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
por: Absalon, Judith, et al.
Publicado: (2022)

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
por: Shoushtari, Mohammad, et al.
Publicado: (2022)

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development
por: Berlanda Scorza, Francesco, et al.
Publicado: (2022)

Physical health and mental health functional status during and following hospitalization for an acute respiratory illness
por: Nowalk, Mary Patricia, et al.
Publicado: (2019)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

Population‐based hospitalization burden estimates for respiratory viruses, 2015–2019
por: Zimmerman, Richard K., et al.
Publicado: (2022)

A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United States
por: Packnett, Elizabeth R., et al.
Publicado: (2022)

Using capture‐recapture methods to estimate influenza hospitalization incidence rates
por: Balasubramani, Goundappa K., et al.
Publicado: (2021)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65
por: Van Ourti, Tom, et al.
Publicado: (2020)

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine
por: Ramani, Sasirekha, et al.
Publicado: (2017)

HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis
por: Rashid, Abdur, et al.
Publicado: (2022)

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants
por: Huang, Yunda, et al.
Publicado: (2021)

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults
por: Russell, Kevin L., et al.
Publicado: (2022)

Determination of Eligibility for Influenza Research: A Clinical Informatics Approach
por: Silveira, Fernanda P, et al.
Publicado: (2019)

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms
por: McCraw, Dustin M., et al.
Publicado: (2016)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population
por: Haney, Douglas J., et al.
Publicado: (2017)

Improving Influenza Vaccination Coverage in the Pediatric Asthma Population: The Case for Combined Methodologies
por: Murphy, Elizabeth V.
Publicado: (2014)

The Burden of Invasive Bacterial Disease and the Impact of 10-Valent Pneumococcal Conjugate Vaccine in Children <5 years hospitalized for Meningitis in Lusaka, Zambia, 2010–2019
por: Yamba, Kaunda, et al.
Publicado: (2021)

Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products
por: Sears, Khandra T., et al.
Publicado: (2017)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lepe9453jt9ukqk55lv1l96cpe